AI Image
Some wellness peptides will become widely available, HHS says
ABC News - Breaking News, Latest News and Videos • • business
Key Points:
- The Health and Human Services (HHS) will temporarily allow compounding pharmacies to make six peptides—BPC-157, TB-500, epitalon, MOTS-c, KPV, and semax—available by prescription, citing safety and patient freedom as reasons.
- These peptides have been promoted online for benefits such as tissue repair, improved skin, and longevity, but scientific evidence supporting these claims remains unclear.
- The policy does not grant FDA approval or confirm clinical safety and effectiveness; it requires patient-specific prescriptions, traceable ingredients, quality testing, and safety reporting to ensure accountability.
- An FDA panel recommended these six peptides for the 503A bulks list, allowing their use in specialized prescriptions, although no clinical trials have proven their effectiveness in humans.
- Doctors warn that these unregulated peptides may be mislabeled, contaminated, or inaccurately dosed, and the FDA previously classified 19 peptides as unsafe for compounding, a move criticized by HHS Secretary Robert F. Kennedy Jr.
